Not available
Quote | Pacific Biosciences of California Inc. (NASDAQ:PACB)
Last: | $1.30 |
---|---|
Change Percent: | 1.56% |
Open: | $1.28 |
Close: | $1.28 |
High: | $1.38 |
Low: | $1.27 |
Volume: | 5,004,794 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | Pacific Biosciences of California Inc. (NASDAQ:PACB)
2024-07-02 11:20:47 ET Summary This article will outline nine steps I use to identify the most promising pharmaceutical companies and avoid investment pitfalls. In addition, each of the nine steps will provide examples of various factors and how they influence the assessment of th...
2024-06-27 10:17:45 ET Information Technology has been the best performing name among all 11 S&P 500 ( SP500 ) sectors in the first half of 2024, but Cathie Wood’s actively managed ARK Innovation ETF ( NYSEARCA: ARKK ) - which aims to provide investors exposure to dis...
Message Board Posts | Pacific Biosciences of California Inc. (NASDAQ:PACB)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $PACB News Article - Biotech stock Pacific Biosciences could return 50% in 12 months: T | whytestocks | investorshangout | 03/31/2023 6:05:51 PM |
whytestocks: $PACB News Article - PacBio Launches Single-Cell Transcriptome Solution Ushering in a N | whytestocks | investorshangout | 10/20/2022 3:05:53 PM |
whytestocks: $PACB News Article - PacBio to Participate in the Morgan Stanley 20th Annual Global Hea | whytestocks | investorshangout | 09/07/2022 8:36:03 PM |
As I said earlier $4 coming! | OptimusPrime555 | investorshub | 08/22/2022 3:32:30 PM |
Back to $4 | OptimusPrime555 | investorshub | 08/15/2022 6:31:58 PM |
News, Short Squeeze, Breakout and More Instantly...
Pacific Biosciences of California Inc. Company Name:
PACB Stock Symbol:
NASDAQ Market:
Pacific Biosciences of California Inc. Website:
PacBio and International Research Consortium CoLoRS Announce Release of First-Ever HiFi Long-Read Variant Database PR Newswire Consortium Delivers Publicly Available Datasets that Enrich Detection of Rare and Novel Genetic Variants for Advances in Human Disease Research ...
Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases PR Newswire Consortium Selects Leading Genomics Companies to Support Pediatric Mendelian Genomics Research Center Program ...